Compare · ETN vs TMO
ETN vs TMO
Side-by-side comparison of Eaton Corporation PLC (ETN) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- ETN operates in Technology, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $177.93B, about 1.1x ETN ($168.00B).
- Over the past year, ETN is up 43.5% and TMO is up 14.2% - ETN leads by 29.3 points.
- TMO has been more active in the news (9 items in the past 4 weeks vs 6 for ETN).
- Both have 25 recent analyst ratings on file.
- Company
- Eaton Corporation PLC
- Thermo Fisher Scientific Inc
- Price
- $433.24+5.45%
- $479.36+2.79%
- Market cap
- $168.00B
- $177.93B
- 1M return
- +21.10%
- -2.51%
- 1Y return
- +43.49%
- +14.23%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 6
- 9
- Recent ratings
- 25
- 25
Eaton Corporation PLC
Eaton Corporation plc operates as a power management company. Its Electrical Americas and Electrical Global segment provides electrical components, industrial components, power distribution and assemblies, residential products, single and three phase power quality products, wiring devices, circuit protection products, utility power distribution products, power reliability equipment, and services in North and South America, as well as hazardous duty electrical, emergency lighting, fire detection, explosion-proof instrumentation, and structural support systems internationally. The company's Hydraulics segment provides pumps, motors, and hydraulic power units; valves, cylinders, and electronic controls; industrial and hydraulic hoses, fittings, assemblies, thermoplastic hose and tubing products, couplings, connectors, and assembly equipment; and industrial drums and disc brakes. Its Aerospace segment offers pumps, motors, hydraulic power units, hoses and fittings, and electro-hydraulic pumps; valves, cylinders, electronic controls, electromechanical actuators, sensors, aircraft flap and slat systems, and nose wheel steering systems; thermoplastic tubing products, fittings, adapters, couplings, and sealing and ducting products; fuel pumps, sensors, valves, and adapters and regulators; and wiring connectors and cables, as well as hydraulic and bag filters, strainers and cartridges, and golf grips. The company's Vehicle segment offers transmissions, clutches, hybrid power systems, superchargers, engine valves and valve actuation systems, cylinder heads, locking and limited slip differentials, transmission controls, and fuel vapor components for the vehicle industry. Its eMobility segment provides voltage inverters, converters, fuses, onboard chargers, circuit protection units, vehicle controls, power distribution systems, fuel tank isolation valves, and commercial vehicle hybrid systems. The company was founded in 1916 and is based in Dublin, Ireland.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest ETN
- Eaton Corporation PLC filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Eaton Declares Quarterly Dividend Payable May 29, 2026
- Eaton to announce first quarter 2026 earnings on May 5, 2026
- Eaton Expands Aerospace Authorized Service Center Agreement With Air Support to Broaden Repair Capabilities in EMEA
- Eaton Earns Prestigious Gold Medal Rating From EcoVadis for Sustainability Management Maturity
- Eaton Expands Operations in Nebraska with New Manufacturing Facility to Meet Increasing Switchgear Demand Driven by AI Data Center Boom
- SEC Form 4 filed by Foster David B
- BMO Capital Markets initiated coverage on Eaton with a new price target
- Amendment: SEC Form SCHEDULE 13G/A filed by Eaton Corporation PLC
- SEC Form 4 filed by Ruiz Sternadt Paulo
Latest TMO
- President & COO Pettiti Gianluca sold $185,064 worth of shares (400 units at $462.66) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 25,051 units (SEC Form 4)
- Thermo Fisher Scientific to Host Investor Day
- Thermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to Astorg
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Thermo Fisher Scientific Reports First Quarter 2026 Results
- AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages
- Thermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PRECISE-SG100K Singapore to Advance Population-Scale Proteomics
- SEC Form DEFA14A filed by Thermo Fisher Scientific Inc
- SEC Form DEF 14A filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 23, 2026